Results 281 to 290 of about 4,780,747 (384)
Abstract Objective To clinically validate the contribution of a custom‐built EEG wearable device (waEEG) compared to a full 10–20 electrode array ambulatory EEG (aEEG) for screening epilepsy cases in patients with suspected temporal lobe epilepsy (TLE) but negative routine EEGs. Methods Patients (aged 16–91 years) with clinically suspected TLE who were
Daniel Filipe Borges+4 more
wiley +1 more source
Integrating Ambulatory Care Pharmacists Into Value-Based Primary Care: A Scalable Solution to Chronic Disease. [PDF]
Blood AJ+10 more
europepmc +1 more source
A. O'Malley+2 more
semanticscholar +1 more source
Rest‐activity rhythm phenotypes in adults with epilepsy and intellectual disability
Abstract Objective Rest‐activity rhythms (RARs) are perturbed in many forms of neuropsychiatric illness. In this study, we applied wrist actigraphy to describe RAR perturbations in intellectually disabled adults with epilepsy (“E + ID”), using a cross‐sectional case–control design.
Nandani Adhyapak+3 more
wiley +1 more source
Operation Polypharmacy: a pharmacist-led ambulatory care clinic design and evaluation for older patients. [PDF]
Tantipinichwong N, Keller MS.
europepmc +1 more source
Abstract Objective Epilepsy is a common condition associated with significant morbidity, mortality, and costs. Poor documentation of seizures is a major challenge in epilepsy care. Objective seizure counting with mobile devices may mitigate this challenge and improve patient management.
Matthew McWilliam+8 more
wiley +1 more source
Association between pre-existing Pulmonary Hypertension and COVID-19 related outcomes in inpatient and ambulatory care settings. [PDF]
Vijayakumar S+14 more
europepmc +1 more source
Time-efficient Preceptors in Ambulatory Care Settings
Richard P. Usatine+2 more
openalex +1 more source
Precision therapies for genetic epilepsies in 2025: Promises and pitfalls
Abstract By targeting the underlying etiology, precision therapies offer an exciting paradigm shift to improve the stagnant outcomes of drug‐resistant epilepsies, including developmental and epileptic encephalopathies. Unlike conventional antiseizure medications (ASMs) which only treat the symptoms (seizures) but have no effect on the underlying ...
Shuyu Wang+3 more
wiley +1 more source